Search research articles
Contact Us
Filters
Showing results (241-250 of 251) with videos related to
Page
of 26
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 1, 1995
T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1
J O Ojwang, R W Buckheit, Y Pommier, et al.
Molecular and Cellular Biology
|
February 18, 1999
Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin
F Carrier, P T Georgel, P Pourquier, et al.
British Journal of Cancer
|
September 19, 2002
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
A H van Hattum, I J Hoogsteen, H M M Schlüper, et al.
Journal of the National Cancer Institute
|
February 26, 1999
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
H M Koo, M Gray-Goodrich, G Kohlhagen, et al.
Journal of Medicinal Chemistry
|
August 28, 1999
Thiazolothiazepine inhibitors of HIV-1 integrase
N Neamati, J A Turpin, H E Winslow, et al.
Oncogene
|
July 19, 2011
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
G Zoppoli, S Solier, W C Reinhold, et al.
Journal of Medicinal Chemistry
|
October 29, 2000
The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity
D Bom, D P Curran, S Kruszewski, et al.
Journal of Medicinal Chemistry
|
April 23, 1999
Chicoric acid analogues as HIV-1 integrase inhibitors
Z Lin, N Neamati, H Zhao, et al.
Cell
|
November 26, 1999
Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions
Y X Wang, N Neamati, J Jacob, et al.
Nature Communications
|
January 10, 2019
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis
S A Baechler, V M Factor, I Dalla Rosa, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 251) with videos related to
Sort By:
Page
of 26
Antimicrobial Agents and Chemotherapy
|
November 1, 1995
T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1
J O Ojwang, R W Buckheit, Y Pommier, et al.
Molecular and Cellular Biology
|
February 18, 1999
Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin
F Carrier, P T Georgel, P Pourquier, et al.
British Journal of Cancer
|
September 19, 2002
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
A H van Hattum, I J Hoogsteen, H M M Schlüper, et al.
Journal of the National Cancer Institute
|
February 26, 1999
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
H M Koo, M Gray-Goodrich, G Kohlhagen, et al.
Journal of Medicinal Chemistry
|
August 28, 1999
Thiazolothiazepine inhibitors of HIV-1 integrase
N Neamati, J A Turpin, H E Winslow, et al.
Oncogene
|
July 19, 2011
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
G Zoppoli, S Solier, W C Reinhold, et al.
Journal of Medicinal Chemistry
|
October 29, 2000
The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity
D Bom, D P Curran, S Kruszewski, et al.
Journal of Medicinal Chemistry
|
April 23, 1999
Chicoric acid analogues as HIV-1 integrase inhibitors
Z Lin, N Neamati, H Zhao, et al.
Cell
|
November 26, 1999
Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions
Y X Wang, N Neamati, J Jacob, et al.
Nature Communications
|
January 10, 2019
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis
S A Baechler, V M Factor, I Dalla Rosa, et al.
Page
of 26